Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Glenmark Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]13145.8411813.1012725.4312174.2010806.03
Other Operating Revenues175.900.00264.68130.71137.90
Total Operating Revenues13321.7411813.1012990.1112304.9010943.93
      
Other Income113.72839.99316.79166.6750.22
Total Revenue13435.4612653.0913306.9012471.5810994.15
      
EXPENSES     
Cost Of Materials Consumed3001.273157.823593.793278.763137.81
Purchase Of Stock-In Trade1566.001451.171268.261117.67750.27
Operating And Direct Expenses0.000.000.0074.4244.99
Changes In Inventories Of FG,WIP And Stock-In Trade-213.93-195.62-325.09-11.14-189.25
Employee Benefit Expenses3022.062868.142780.962447.422343.71
Finance Costs207.07515.97349.58298.10353.11
Depreciation And Amortisation Expenses486.01581.91611.27486.72443.55
Other Expenses3594.963336.253393.833077.482772.03
Total Expenses11663.4311715.6411672.5910769.429656.22
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1772.03937.451634.311702.161337.93
      
Exceptional Items-372.82-900.96-765.85-260.9144.55
Profit/Loss Before Tax1399.2136.50868.451441.251382.48
      
Tax Expenses-Continued Operations     
Current Tax352.071115.55566.90546.65498.14
Deferred Tax0.00751.79-75.85-99.05-85.75
Total Tax Expenses352.071867.35491.05447.60412.39
Profit/Loss After Tax And Before ExtraOrdinary Items1047.14-1830.85377.40993.65970.09
      
Profit/Loss From Continuing Operations1047.14-1830.85377.40993.65970.09
      
Profit/Loss From Discontinuing Operations0.00397.330.000.000.00
Net Profit/Loss From Discontinuing Operations0.00397.330.000.000.00
Profit/Loss For The Period1047.14-1433.52377.40993.65970.09
      
Minority Interest-0.05-68.15-80.16-51.94-0.05
Consolidated Profit/Loss After MI And Associates1047.10-1501.67297.25941.71970.04
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)37.11-53.2210.5333.3734.38
Diluted EPS (Rs.)37.11-53.2210.5333.3734.38
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.0070.5470.5470.5470.54
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]13145.84
Other Operating Revenues175.90
Total Operating Revenues13321.74
Other Income113.72
Total Revenue13435.46
EXPENSES 
Cost Of Materials Consumed3001.27
Purchase Of Stock-In Trade1566.00
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade-213.93
Employee Benefit Expenses3022.06
Finance Costs207.07
Depreciation And Amortisation Expenses486.01
Other Expenses3594.96
Total Expenses11663.43
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1772.03
Exceptional Items-372.82
Profit/Loss Before Tax1399.21
Tax Expenses-Continued Operations 
Current Tax352.07
Deferred Tax0.00
Total Tax Expenses352.07
Profit/Loss After Tax And Before ExtraOrdinary Items1047.14
Profit/Loss From Continuing Operations1047.14
Profit/Loss From Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period1047.14
Minority Interest-0.05
Consolidated Profit/Loss After MI And Associates1047.10
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)37.11
Diluted EPS (Rs.)37.11
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00